Get the Stockscreener App
1.42
1.39%
-0.02
After Hours:
1.40
-0.02
-1.41%
Painreform Ltd stock is traded at $1.42, with a volume of 112.00K.
It is down -1.39% in the last 24 hours and up +4.91% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$1.44
Open:
$1.42
24h Volume:
112.00K
Relative Volume:
0.04
Market Cap:
$2.86M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.1989
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
+0.00%
1M Performance:
+4.91%
6M Performance:
-51.37%
1Y Performance:
-57.23%
1-Day Range:
$1.39
$1.44
1-Week Range:
$1.32
$1.47
52-Week Range:
$1.25
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.42 | 2.74M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Painreform Ltd Stock (PRFX) Latest News
Can you recover from losses in PainReform Ltd.Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Applying Elliott Wave Theory to PainReform Ltd.Quarterly Profit Review & Fast Exit and Entry Strategy Plans - Newser
Visual analytics tools that track PainReform Ltd. performance2025 Price Momentum & AI Enhanced Trading Alerts - Newser
Technical analysis overview for PainReform Ltd. stockMarket Performance Report & Real-Time Market Sentiment Alerts - Newser
Will breakout in PainReform Ltd. lead to full recoveryJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser
Can PainReform Ltd. rally from current levelsJuly 2025 Momentum & Community Consensus Picks - Newser
Is this a good reentry point in PainReform Ltd.Global Markets & Community Shared Stock Ideas - Newser
Published on: 2025-09-12 13:45:44 - Newser
Does PainReform Ltd. qualify in momentum factor screeningWeekly Trade Analysis & Consistent Income Trade Ideas - Newser
Detecting price anomalies in PainReform Ltd. with AI2025 AllTime Highs & Verified Momentum Stock Alerts - Newser
Order flow analysis tools used on PainReform Ltd.Weekly Profit Report & Technical Analysis for Trade Confirmation - Newser
What MACD and RSI say about PainReform Ltd.Earnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
How institutional ownership impacts PainReform Ltd. stock2025 Investor Takeaways & Verified Trade Idea Suggestions - Newser
Smart tools for monitoring PainReform Ltd.’s price actionMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
Developing predictive dashboards with PainReform Ltd. dataJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
Price action breakdown for PainReform Ltd.Market Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
What high frequency data says about PainReform Ltd.2025 Price Momentum & Breakout Confirmation Alerts - Newser
Is PainReform Ltd. showing signs of accumulationBuy Signal & Weekly Stock Performance Updates - Newser
How to build a custom watchlist for PainReform Ltd.Quarterly Trade Report & Reliable Momentum Entry Alerts - Newser
PainReform Enters Cataract Surgery Market with LayerBio Investment - MSN
PainReform Ltd.’s volatility index tracking explainedJuly 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
PainReform’s DeepSolar Joins NVIDIA Connect Program to Enhance Solar Forecasting - MSN
Sentiment analysis tools applied to PainReform Ltd.Entry Point & Step-by-Step Swing Trade Plans - Newser
Statistical indicators supporting PainReform Ltd.’s strengthQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
Key metrics from PainReform Ltd.’s quarterly dataPortfolio Performance Summary & Low Risk Entry Point Guides - Newser
Is PainReform Ltd. stock entering bullish territoryWeekly Loss Report & Daily Momentum Trading Reports - Newser
Ranking PainReform Ltd. among high performing stocks via toolsPortfolio Value Summary & Expert Verified Movement Alerts - Newser
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):